Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on H acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113024574B reveals a novel hydrogen peroxide oxidation method for Entecavir intermediate NT02, offering significant yield improvements and cost reduction in pharmaceutical manufacturing.
Advanced synthesis of (4-chloro-naphthalene-2-yl)-methanol via CN118637984A. Delivers high yield, purity, and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN119899823A reveals a novel lipase mutant enabling mild, cost-effective production of chiral pharmaceutical intermediates with superior stereoselectivity.
Patent CN1112346C reveals a stable cobalt catalyst for phenylpyruvic acid. This report analyzes cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN106748768B details a mild Ni-catalyzed synthesis for chiral esters, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN106573005A details a scalable furfural-based route for high-purity agrochemical intermediates, offering significant cost reduction and supply chain reliability for fungicide manufacturing.
Patent CN104193792B reveals a one-step microwave-assisted conversion of chenodeoxycholic acid. This report analyzes cost reduction in API manufacturing and supply chain reliability for high-purity ursodeoxycholic acid.
Advanced synthesis of Capecitabine using trifluoromethanesulfonic acid catalysis eliminates isomer separation, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101538255B details a greener synthesis for SMIA using butyl acetate, reducing solvent loss and byproducts for reliable pharmaceutical intermediate supply.
Patent CN105801578B details a one-step catalytic route for semi-saturated pyrazines, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN118851869A details high-yield synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN120208783A reveals new synthesis for GLP-1 intermediates. Enhances purity and reduces costs for pharmaceutical manufacturing supply chains.
Novel one-pot synthesis method improves yield and reduces environmental impact for pharmaceutical intermediate manufacturing supply chains globally.
Novel enzymatic route for L-Homoserine production offering high efficiency and green processing. Reliable supplier for pharmaceutical intermediates ensuring cost reduction and supply chain stability.
Novel halogenation-hydroxylation route offers safer cost-effective pharmaceutical intermediate manufacturing with high purity and scalability for global supply chains.
Patent CN115894563A reveals a green HPA-catalyzed route for isoindolinones. Discover cost reduction in pharmaceutical intermediates manufacturing and scalable supply solutions.
Advanced refining method for Hyodeoxycholic Acid ensures high purity and safety. Ideal for pharmaceutical intermediates manufacturing with reduced costs and scalable supply chain solutions.
Patent CN103755764B details a scalable synthetic route for taurocholic acid ensuring high purity and cost efficiency for global pharmaceutical supply chains.
Patent CN106946650B reveals a high-yield synthetic route for erlotinib intermediates. Discover cost reduction in API manufacturing and scalable production methods.
Patent CN108069846B reveals a novel resolution method for cis-1-hydroxy-[1,1'-bis(cyclohexyl)]-2-carboxylic acid, eliminating precious metal catalysts for cost-effective pharmaceutical intermediate manufacturing.